BioMarin Pharmaceutical
BMRN
#1731
Rank
NZ$21.34 B
Marketcap
NZ$110.21
Share price
-1.64%
Change (1 day)
17.25%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): NZ$72.73 Million

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are NZ$3.65 Billion. In 2025 the company made an earning of NZ$0.88 Billion a decrease over its 2024 earnings that were of NZ$0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$72.73 M-91.74%
2025 NZ$0.88 B-10.94%
2024 NZ$0.98 B187.31%
2023 NZ$0.34 B26.07%
2022 NZ$0.27 B-298.51%
2021 -NZ$0.14 Billion78.04%
2020 -NZ$77.21 Million-55.36%
2019 -NZ$0.18 Billion-33.56%
2018 -NZ$0.27 Billion297.78%
2017 -NZ$65.45 Million-95.68%
2016 -NZ$1.52 Billion437.12%
2015 -NZ$0.29 Billion23.91%
2014 -NZ$0.23 Billion-29.25%
2013 -NZ$0.33 Billion49.23%
2012 -NZ$0.22 Billion171.11%
2011 -NZ$79.6 Million103.01%
2010 -NZ$39.21 Million-3903.54%
2009 NZ$1.03 M-98.31%
2008 NZ$60.97 M-189.7%
2007 -NZ$67.98 Million51.02%
2006 -NZ$45.02 Million-61.58%
2005 -NZ$0.12 Billion-56.59%
2004 -NZ$0.27 Billion95.13%
2003 -NZ$0.14 Billion12.09%
2002 -NZ$0.13 Billion73.19%
2001 -NZ$71.24 Million18.32%
2000 -NZ$60.21 Million19.65%
1999 -NZ$50.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
NZ$14.20 B 17,735.86%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.82 Billion-1,124.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.21 Billion-352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.14 B 81.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.34 M-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$0.54 B 578.94%๐Ÿ‡บ๐Ÿ‡ธ USA